Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

PDF) Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial

PDF) Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial

Effectiveness of nifedipine, labetalol, and

Hypertensive Disorders in Pregnancy and Eclampsia (Chapter 25) - The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology

Healthcare, Free Full-Text

PDF] Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial

Prevention Starts in the Womb: Opportunities for Addressing Cardiovascular Risk Factors During Pregnancy and Beyond - Methodist DeBakey Cardiovascular J

Healthcare, Free Full-Text

Oral labetalol versus oral nifedipine for the management of postpartum hypertension a randomized control trial. - Abstract - Europe PMC

Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study

Maternal Medicine (Section 4) - The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology

A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia - Poon - 2021 - International Journal of Gynecology & Obstetrics - Wiley Online Library